Risk, disorder and diagnosis

Australian and New Zealand Journal of Psychiatry

Volumn 45, Issue 11, 2011, Pages 915-919

  Yung, Alison R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; NEUROLEPTIC AGENT;

ATTENUATED PSYCHOSIS SYNDROME; CLINICAL FEATURE; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERROR; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; MENTAL HEALTH; PSYCHOSIS; REVIEW; RISK FACTOR; RISK SYNDROME FOR PSYCHOSIS; SCHIZOPHRENIA; THERAPEUTIC ERROR; UNSPECIFIED SIDE EFFECT;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EARLY DIAGNOSIS; HUMANS; RISK FACTORS; SCHIZOPHRENIA;

EID: 80555145989     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2011.614926     Document Type: Review

References (60)

1. Gottesman II. Schizophrenia genesis: The origin of madness. New York: Freeman, 1991.
2. Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P. Signs of asphixia at birth and risk of schizophrenia: Populationbased case-control study. Br J Psychiatry 2001; 179:403-408.
3. Kunugi H, Nanko S, Murray RM. Obstetric complications and schizophrenia: Prenatal underdevelopment and subsequent neurodevelopmental impairment. Br J Psychiatry 2001; 178S40: 25-29.
4. Jones P, Rodgers B, Murray R, Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994; 344:1398-1402.
5. Cannon M, Caspi A, Moffitt TE et al. Evidence for early-childhood pan-developmental impairment specifi c to schizophreniform disorder: Tesults from a longitudinal birth cohort. Arch Gen Psychiatry 2002; 59:449-457.
6. Read J, van Os J, Morrison A, Ross CA. Childhood trauma, psychosis and schizophrenia: A literature review with theoretical and clinical implications. Acta Psychiatr Scand 2005; 112:330-350.
7. Yung A, McGorry PD. The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophr Bull 1996; 22:353-370.
8. Yung AR, Phillips LJ, Yuen HP et al. Psychosis prediction: 12-month follow up of a high-risk ('prodromal') group. Schizophr Res 2003; 60:21-32.
9. Moller P, Husby R. The initial prodrome in schizophrenia: Searching for naturalistic core dimensions of experience and behavior. Schizophr Bull 2000; 26:217-232.
10. Scott J, Chant D, Andrews G, McGrath J. Psychotic-like experiences in the general community: The correlates of CIDI psychosis screen items in an Australian sample. Psychol Med 2006; 36: 231-238.
11. Tien AY. Distributions of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol 1991; 26:287-292.
12. Van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Arch Gen Psychiatry 2001; 58: 663-668.
13. Van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A sytematic review and meta-analysis of the psychosis continuum: Evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009; 39:179-195.
14. Yung AR, Nelson B, Baker K, Buckby J, Baksheev G, Cosgrave E. Psychotic-like experiences in a community sample of adolescents: Implications for the continuum model of psychosis and prediction of schizophrenia. Aust N Z J Psychiatry 2009; 43:118-128.
15. McGorry PD. Pre-emptive intervention in psychosis: Agnostic rather than diagnostic. Aust N Z J Psychiatry 2011; 45:515-519.
16. Yung AR, Phillips LJ, McGorry PD. Treating schizophrenia in the prodromal phase. London: Taylor and Francis; 2004.
17. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophr Res 2004; 67:131-42.
18. Cannon TD, Cadenhead K, Cornblatt B et al. Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America. Arch Gen Psychiatry 2008; 65:28-37.
19. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: Review of studies. Acta Psychiatr Scand 2006; 113:247-272.
20. Yung AR, Yuen HP, Berger G et al. Declining transition rate in ultra high risk (prodromal) services: Dilution or reduction of risk? Schizophr Bull 2007; 33:673-681.
21. Ruhrmann S, Schultze-Lutter F, Salokangas RKR et al. Prediction of psychosis in adolescents and young adults at high risk: Results from the prospective European Prediction of Psychosis Study. Arch Gen Psychiatry 2010; 67:241-251.
22. Demjaha A, Valmaggia L, Stahl D, Byrne M, McGuire P. Disorganization/ cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull 2010. doi:10.1093/schbul/ sbq088
23. Simon AE, Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res 2010; 116: 168-172.
24. Lemos-Giráldez S, Vallina-Fernández O, Fernández- Iglesias P et al. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: A longitudinal study. Schizophr Res 2009; 115: 121-129.
25. Riecher-Rossler A, Pfl ueger MO, Aston J et al. Effi cacy of using cognitive status in predicting psychosis: A 7-year follow-up. Biol Psychiatry 2009; 66:1023-1030.
26. Broome MR, Woolley JB, Johns LC et al. Outreach and support in south London (OASIS): Implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry 2005; 20:372-378.
27. Haroun N, Dunn L, Haroun A, Cadenhead K. Risk and protection in prodromal schizophrenia: Ethical implications for clinical practice and future research. Schizophr Bull 2006; 32:166-178.
28. McGlashan TH, Addington J, Cannon T et al. Recruitment and treatment practices for help-seeking'prodromal'patients. Schizophr Bull 2007; 33:715-726.
29. Rosenman S, Anderson P. Does prodromal diagnosis delay early intervention? Aust N Z J Psychiatry 2011; 45:509-514.
30. McGlashan TH, Zipursky RB, Perkins D et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163: 790-799.
31. McGorry PD, Yung AR, Phillips LJ et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59:921-928.
32. Yung AR, Phillips LJ, Nelson B et al. Randomized controlled trial of interventions for young people at ultra high risk of psychosis: 6 month analysis. J Clin Psychiatry 2011; 72:430-440.
33. Morrison AP, French P, Walford L et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. Br J Psychiatry 2004; 185:291-297.
34. Amminger GP, Schäfer M, Papageorgiou K et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67:146-154.
35. Drake R, Lewis S. Valuing prodromal psychosis: What do we get and what is the price? Schizophr Res 2010; 120:38-41.
36. Yung AR, Nelson B, Thompson AD, Wood SJ. Should a'risk syndrome for psychosis'be included in the DSM-V? Schizophr Res 2010; 120:7-15.
37. Nelson B, Yung AR. Should a risk syndrome for first episode psychosis be included in DSM-V? Curr Op Psychiatry 2011; 24:128-133.
38. Woods SW, Walsh BC, Saksa JR, McGlashan TH. The case for including attenuated psychotic symptoms syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res 2010; 123:199-207.
39. McGorry PD. Risk syndromes, clinical staging and DSM-V: New diagnostic infrastructure for early intervention in psychiatry. Schizophr Res 2010; 120:49-53.
40. Corcoran C, First MB, Cornblatt B. The psychosis risk syndrome and its proposed inclusion in the DSM-V: A risk-benefi t analysis. Schizophr Res 2010; 120:16-22.
41. Ruhrmann S, Schulze-Lutter F, Klosterkoetter J. Probably at-risk, but certainly ill-advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 2010; 120:23-37.
42. Yang LH, Wonpat-Borja AJ, Opler MG, Corcoran CM. Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: An empirical question. Schizophr Res 2010; 120:42-48.
43. Carpenter WT. Anticipating DSM-V: Should psychosis risk become a diagnostic class? Schizophr Bull 2009; 35:841-843.
44. David AS. Should the diagnostic boundaries of schizophrenia be expanded? Cogn Neuropsychiatry 2011; 16:97-100.
45. Johannessen JO, McGorry P. DSM-5 and the'psychosis risk syndrome': The need for a broader perspective. Psychosis: Psychol Soc Integr Approach 2010; 2:93-96.
46. Ross CA. DSM-5 and the'psychosis risk syndrome': Eight reasons to reject it. Psychosis: Psychol Soc Integr Approach 2010; 2:107-110.
47. Carpenter WT. Should attenuated psychosis syndrome be a DSM-5 diagnosis? Amer J Psychiatry 2011; 168:460-463.
48. Cooper R. What is wrong with the DSM? Hist Psychiatry 2004; 15:5-25.
49. Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Ann Rev Clin Psychol 2007; 3:1-27.
50. Shendler J. The effi cacy of psychodynamic psychotherapy. A m Psychol 2010; 65:98-109.
51. Tucker GJ. Putting DSM IV in perspective. Am J Psychiatry 1998; 155:159-161.
52. Anand S, Malhi GS. From manual to Bible: The questionable hegemony of DSM IV. Aust N Z J Psychiatry 2011; 45: 348-350.
53. Andreasen NC. DSM and the death of phenomenology in America: An example of unintended consequences. Schizophr Bull 2007; 33:108-112.
54. Kendler KS, Munoz RA, Murphy G. The development of the Feighner criteria: A historical perspective. Am J Psychiatry 2010; 167:134-142.
55. Svirskis T, Korkeila J, Heinimaa M et al. Axis-I disorders and vulnerability to psychosis. Schizophr Res 2005, 439-446.
56. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecifi c and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res 2004; 68: 37-48.
57. International Early Psychosis Association, Addington J, Amminger GP et al. International clinical practice guidelines for early psychosis. Br J Psychiatry 2005; 187S48:120-124.
58. McGorry P. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005; 39:1-30.
59. Reich W. The spectrum concept of schizophrenia: Problems for diagnostic practice. Arch Gen Psychiatry 1975; 32:489-498.
60. Corcoran C, Malaspina D, Hercher L. Prodromal interventions for schizophrenia vulnerability: The risks of being'at risk'. Schizophr Res 2005; 73:173-184.